Am J Pathol 143(3): 678-684

Angiogenic macrophages produce the angiogenic inhibitor thrombospondin 1.

Abstract

Previous investigations have shown that macrophages play a pivotal role in the induction of angiogenesis in both physiological and pathological settings. This investigation examines the relative production of the angiogenic modulator thrombospondin-1 (TSP1) by activated and nonactivated monocytes and macrophages. TSP1, a multifunctional extracellular matrix molecule, has been reported recently to inhibit angiogenesis both in vitro and in vivo. To examine the relationship between the level of TSP1 production by macrophages and expression of the angiogenic phenotype, murine monocytelike cells (WEHI-3) and human peripheral blood monocytes were each activated in vitro and examined for TSP1 production and angiogenic activity in rat corneal bioassay. Nonangiogenic monocytes produced low levels of TSP1 messenger RNA. Surprisingly, activated, potently angiogenic monocytes and macrophages exhibited as much as a sixfold increase in steady state TSP1 messenger RNA over unstimulated levels. Biosynthetic labeling studies demonstrated that TSP1 protein secretion increased in conjunction with increased TSP1 messenger RNA levels in angiogenic macrophages. The results demonstrate that activated monocytes and macrophages actively produce the angiogenic modulator TSP1 and suggest that TSP1 production may be a component of the angiogenic phenotype. In addition, the data suggest that the ability of macrophages to mediate angiogenesis results from a complex interplay of positive and negative regulators.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.6M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Images in this article

Figure 1
on p.680

Figure 2
on p.681

Figure 3
on p.682

Click on the image to see a larger version.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Folkman J, Klagsbrun M. Angiogenic factors. Science. 1987 Jan 23;235(4787):442–447. [PubMed] [Google Scholar]
Polverini PJ, Cotran PS, Gimbrone MA, Jr, Unanue ER. Activated macrophages induce vascular proliferation. Nature. 1977 Oct 27;269(5631):804–806. [PubMed] [Google Scholar]
Koch AE, Polverini PJ, Leibovich SJ. Induction of neovascularization by activated human monocytes. J Leukoc Biol. 1986 Feb;39(2):233–238. [PubMed] [Google Scholar]
Thakral KK, Goodson WH, 3rd, Hunt TK. Stimulation of wound blood vessel growth by wound macrophages. J Surg Res. 1979 Apr;26(4):430–436. [PubMed] [Google Scholar]
Hunt TK, Knighton DR, Thakral KK, Goodson WH, 3rd, Andrews WS. Studies on inflammation and wound healing: angiogenesis and collagen synthesis stimulated in vivo by resident and activated wound macrophages. Surgery. 1984 Jul;96(1):48–54. [PubMed] [Google Scholar]
Polverini PJ, Leibovich SJ. Induction of neovascularization in vivo and endothelial proliferation in vitro by tumor-associated macrophages. Lab Invest. 1984 Dec;51(6):635–642. [PubMed] [Google Scholar]
Koch AE, Polverini PJ, Leibovich SJ. Stimulation of neovascularization by human rheumatoid synovial tissue macrophages. Arthritis Rheum. 1986 Apr;29(4):471–479. [PubMed] [Google Scholar]
Porras-Reyes BH, Blair HC, Jeffrey JJ, Mustoe TA. Collagenase production at the border of granulation tissue in a healing wound: macrophage and mesenchymal collagenase production in vivo. Connect Tissue Res. 1991;27(1):63–71. [PubMed] [Google Scholar]
Sunderkötter C, Goebeler M, Schulze-Osthoff K, Bhardwaj R, Sorg C. Macrophage-derived angiogenesis factors. Pharmacol Ther. 1991;51(2):195–216. [PubMed] [Google Scholar]
Jaffe EA, Ruggiero JT, Falcone DJ. Monocytes and macrophages synthesize and secrete thrombospondin. Blood. 1985 Jan;65(1):79–84. [PubMed] [Google Scholar]
Frazier WA. Thrombospondin: a modular adhesive glycoprotein of platelets and nucleated cells. J Cell Biol. 1987 Aug;105(2):625–632.[PMC free article] [PubMed] [Google Scholar]
Lawler J. The structural and functional properties of thrombospondin. Blood. 1986 May;67(5):1197–1209. [PubMed] [Google Scholar]
Rastinejad F, Polverini PJ, Bouck NP. Regulation of the activity of a new inhibitor of angiogenesis by a cancer suppressor gene. Cell. 1989 Feb 10;56(3):345–355. [PubMed] [Google Scholar]
Good DJ, Polverini PJ, Rastinejad F, Le Beau MM, Lemons RS, Frazier WA, Bouck NP. A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin. Proc Natl Acad Sci U S A. 1990 Sep;87(17):6624–6628.[PMC free article] [PubMed] [Google Scholar]
Iruela-Arispe ML, Bornstein P, Sage H. Thrombospondin exerts an antiangiogenic effect on cord formation by endothelial cells in vitro. Proc Natl Acad Sci U S A. 1991 Jun 1;88(11):5026–5030.[PMC free article] [PubMed] [Google Scholar]
Bagavandoss P, Wilks JW. Specific inhibition of endothelial cell proliferation by thrombospondin. Biochem Biophys Res Commun. 1990 Jul 31;170(2):867–872. [PubMed] [Google Scholar]
Taraboletti G, Roberts D, Liotta LA, Giavazzi R. Platelet thrombospondin modulates endothelial cell adhesion, motility, and growth: a potential angiogenesis regulatory factor. J Cell Biol. 1990 Aug;111(2):765–772.[PMC free article] [PubMed] [Google Scholar]
Vissers MC, Jester SA, Fantone JC. Rapid purification of human peripheral blood monocytes by centrifugation through Ficoll-Hypaque and Sepracell-MN. J Immunol Methods. 1988 Jun 13;110(2):203–207. [PubMed] [Google Scholar]
Hennessy SW, Frazier BA, Kim DD, Deckwerth TL, Baumgartel DM, Rotwein P, Frazier WA. Complete thrombospondin mRNA sequence includes potential regulatory sites in the 3' untranslated region. J Cell Biol. 1989 Feb;108(2):729–736.[PMC free article] [PubMed] [Google Scholar]
Feinberg AP, Vogelstein B. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem. 1983 Jul 1;132(1):6–13. [PubMed] [Google Scholar]
Adams DO, Koerner TJ. Gene regulation in macrophage development and activation. Year Immunol. 1989;4:159–180. [PubMed] [Google Scholar]
Varani J, Stoolman L, Wang T, Schuger L, Flippen C, Dame M, Johnson KJ, Todd RF, 3rd, Ryan US, Ward PA. Thrombospondin production and thrombospondin-mediated adhesion in U937 cells. Exp Cell Res. 1991 Jul;195(1):177–182. [PubMed] [Google Scholar]
Ostergaard E, Flodgaard H. A neutrophil-derived proteolytic inactive elastase homologue (hHBP) mediates reversible contraction of fibroblasts and endothelial cell monolayers and stimulates monocyte survival and thrombospondin secretion. J Leukoc Biol. 1992 Apr;51(4):316–323. [PubMed] [Google Scholar]
Besner GE, Klagsbrun M. Macrophages secrete a heparin-binding inhibitor of endothelial cell growth. Microvasc Res. 1991 Sep;42(2):187–197. [PubMed] [Google Scholar]
Silverstein RL, Nachman RL. Thrombospondin binds to monocytes-macrophages and mediates platelet-monocyte adhesion. J Clin Invest. 1987 Mar;79(3):867–874.[PMC free article] [PubMed] [Google Scholar]
Huber AR, Ellis S, Johnson KJ, Dixit VM, Varani J. Monocyte diapedesis through an in vitro vessel wall construct: inhibition with monoclonal antibodies to thrombospondin. J Leukoc Biol. 1992 Nov;52(5):524–528. [PubMed] [Google Scholar]
Hogg PJ, Stenflo J, Mosher DF. Thrombospondin is a slow tight-binding inhibitor of plasmin. Biochemistry. 1992 Jan 14;31(1):265–269. [PubMed] [Google Scholar]
Mansfield PJ, Boxer LA, Suchard SJ. Thrombospondin stimulates motility of human neutrophils. J Cell Biol. 1990 Dec;111(6 Pt 2):3077–3086.[PMC free article] [PubMed] [Google Scholar]
Savill J, Hogg N, Ren Y, Haslett C. Thrombospondin cooperates with CD36 and the vitronectin receptor in macrophage recognition of neutrophils undergoing apoptosis. J Clin Invest. 1992 Oct;90(4):1513–1522.[PMC free article] [PubMed] [Google Scholar]

Department of Pathology, Northwestern University, Chicago, Illinois.

Abstract